华夏中证500自由现金流ETF今日发布上市公告书，基金将于2025年8月5日上市，上市交易份额为3.87 亿份，该基金成立日为2025年7月23日，截至2025年7月29日，基金投资组合中，银行存款和结算备付金 合计占基金总资产的比例为64.45%，股票投资占基金总资产的比例为35.55%，目前基金仍处于建仓 期。 证券时报·数据宝统计，7月以来共有31只股票型ETF公告上市，平均仓位仅为19.32%，仓位最高的是汇 添富国证通用航空产业ETF，仓位为42.30%，仓位居前的还有鹏华科创板芯片ETF、华夏中证500自由 现金流ETF、华夏上证智选科创板价值50策略ETF，仓位分别为39.29%、35.55%、34.07%，仓位较低的 为华宝恒生港股通创新药精选ETF、博时恒生港股通创新药精选ETF、天弘中证A100ETF，仓位分别为 0.00%、0.00%。 一般来说，ETF上市都要满足基金合同规定的仓位要求，发布上市公告书，距离正式上市时间会差几个 交易日，其间如果仓位较低，会在上市前完成建仓。 7月以来公告上市的ETF中，按上市交易份额统计，平均募集4.61亿份，规模居前的有广发恒生港股通 科技主题ETF ...

Group 1 - Since July, multiple technology-themed funds have ended their fundraising early, indicating a growing enthusiasm for subscriptions and a shift towards technology sectors [1] - The early closure of funds reflects a preference for growth assets and highlights the technology innovation sector as a core direction for medium to long-term capital allocation [1] - In July, the China Ocean Fund announced the early closure of its technology innovation mixed fund, marking it as the seventh technology-related fund to end fundraising early this month [1] Group 2 - Experts attribute the "lightning fundraising" phenomenon to several driving factors, including significant policy support and industry trends that enhance long-term confidence in hard technology sectors [2] - Many technology-themed funds have preset fundraising caps, which, in the context of high subscription enthusiasm and rapid capital inflow, leads to early achievement of target sizes [2] - The valuation attractiveness of technology stocks has improved after prior adjustments, prompting some fund companies to accelerate their investment through early fundraising closures [2] Group 3 - The liquidity environment has been improving, with the People's Bank of China releasing liquidity through significant reverse repurchase operations [3] - Regulatory support for the funding environment and changes in macro fundamentals are expected to enhance investor risk appetite [3] - The technology innovation sector is seen as having significant investment value, particularly in rapidly growing areas like artificial intelligence and advancements in biomedicine [3]